These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11441328)

  • 21. Omalizumab and the immune system: an overview of preclinical and clinical data.
    Johansson SG; Haahtela T; O'Byrne PM
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):132-8. PubMed ID: 12197568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omalizumab in asthma: an update on recent developments.
    Humbert M; Busse W; Hanania NA; Lowe PJ; Canvin J; Erpenbeck VJ; Holgate S
    J Allergy Clin Immunol Pract; 2014; 2(5):525-36.e1. PubMed ID: 25213045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy.
    Soriano Gomis V; Gonzalez Delgado P; Niveiro Hernandez E
    J Investig Allergol Clin Immunol; 2008; 18(3):225-6. PubMed ID: 18564638
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.
    Belloni B; Ziai M; Lim A; Lemercier B; Sbornik M; Weidinger S; Andres C; Schnopp C; Ring J; Hein R; Ollert M; Mempel M
    J Allergy Clin Immunol; 2007 Nov; 120(5):1223-5. PubMed ID: 17936892
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-IgE therapy: clinical utility beyond asthma.
    Casale TB; Stokes J
    J Allergy Clin Immunol; 2009 Apr; 123(4):770-1.e1. PubMed ID: 19348915
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases.
    D'Amato G; Oldani V; Donner CF
    Monaldi Arch Chest Dis; 2003; 59(1):25-9. PubMed ID: 14533279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.
    Kim DH; Park KY; Kim BJ; Kim MN; Mun SK
    Clin Exp Dermatol; 2013 Jul; 38(5):496-500. PubMed ID: 23083013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ALLERGIC DISEASES AND ASTHMA IN ADOLESCENTS.
    Adamia N; Jorjoliani L; Khachapuridze D; Katamadze N; Chkuaseli N
    Georgian Med News; 2015 Jun; (243):58-62. PubMed ID: 26087732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attainments in atop: special aspects of allergy and IgE.
    Milgrom H
    Adv Pediatr; 2002; 49():273-97. PubMed ID: 12214775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of allergic rhinitis and other immunoglobulin E-mediated diseases with anti-immunoglobulin E antibody.
    Berger WE
    Allergy Asthma Proc; 2006; 27(2 Suppl 1):S29-32. PubMed ID: 16722329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis.
    Kuehr J; Brauburger J; Zielen S; Schauer U; Kamin W; Von Berg A; Leupold W; Bergmann KC; Rolinck-Werninghaus C; Gräve M; Hultsch T; Wahn U
    J Allergy Clin Immunol; 2002 Feb; 109(2):274-80. PubMed ID: 11842297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
    Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
    Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omalizumab for treatment of allergic rhinitis.
    Vashisht P; Casale T
    Expert Opin Biol Ther; 2013 Jun; 13(6):933-45. PubMed ID: 23621175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with monoclonal antibodies in allergic mediated disease: seasonal allergic rhinitis.
    Casale TB
    J Allergy Clin Immunol; 2001 Aug; 108(2 Suppl):S84-8. PubMed ID: 11498678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on mechanisms of allergen injection immunotherapy.
    James LK; Durham SR
    Clin Exp Allergy; 2008 Jul; 38(7):1074-88. PubMed ID: 18691292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in human basophils IgE-mediated stimulation by omalizumab: a role for membrane FcγRs?
    Chirumbolo S; Olivieri M
    J Allergy Clin Immunol; 2014 May; 133(5):1493-4. PubMed ID: 24642141
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-immunoglobulin E for the treatment of allergic disease.
    Busse W; Neaville W
    Curr Opin Allergy Clin Immunol; 2001 Feb; 1(1):105-8. PubMed ID: 11964677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-IgE therapy in asthma: rationale and therapeutic potential.
    Barnes PJ
    Int Arch Allergy Immunol; 2000 Nov; 123(3):196-204. PubMed ID: 11112855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy].
    Scheinmann P; Pham Thi N; Karila C; de Blic J
    Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.